It is widely recognized that severed axons in the adult central nervous system (CNS) have limited capacity to regenerate. However, mounting evidence from studies of CNS injury response and repair is challenging the prevalent view that the adult mammalian CNS is incapable of structural reorganization to adapt to an altered environment. Animal studies demonstrate the potential to achieve significant anatomical repair and functional recovery following CNS injury by manipulating axon growth regulators alone or in combination with activity-dependent strategies. With a growing understanding of the cellular and molecular mechanisms regulating axon plasticity, and the availability of new experimental tools to map detour circuits of functional importance, directing circuit rewiring to promote functional recovery may be achieved.
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Axon plasticity following injury
The adult mammalian central nervous system (CNS) is commonly perceived as a rigid network resistant to change. This is in part true, as demonstrated by the detrimental and often permanent effects of CNS injury that result from its lack of regenerative ability. However, accumulating evidence suggests that genetic and biopharmacological manipulations can induce regeneration of severed axons. Additionally, extensive axonal sprouting occurs spontaneously in a number of mammalian species, including primates, following spinal cord injury (SCI). In this review, axon plasticity is defined as the ability of axons to undergo structural changes to adapt to an altered environment. It occurs on the levels of axon regeneration and sprouting, the modulation of which has the potential to restore functions after axon injury. While axon regeneration is naturally repressed in the CNS by a combination of neuron-extrinsic inhibitors and a lack of neuron-intrinsic growth capacity, axon sprouting occurs spontaneously and can restore limited function in rodent models of incomplete SCI. Although sprouting is deemed a form of spontaneous plasticity that can be exploited for therapeutic gain, surprisingly little is known about its regulation and anatomical organization.
In this review, we will discuss: (i) molecular regulators of axon growth and reorganization primarily in the context of rodent spinal cord injury models, given that the use of mouse genetics is becoming prevalent in examining molecular mechanisms of the regenerative response; (ii) circuit remodeling by spontaneous sprouting and latent pathway activation after CNS axon injury; (iii) therapeutic potential of combining rehabilitation with growth-enhancing strategies to achieve functional recovery; and (iv) current challenges in neural regeneration research.
Regeneration of lesioned axons at and around the injury site
The intuitive approach to repairing axonal injury is to promote regeneration of lesioned axons across the injury site; that is, to reconnect severed tracts with their original targets. Spurred by the seminal finding that injured CNS axons can grow into the growth-permissive environment of a peripheral nerve graft [1], early efforts in this area focused mainly on identifying inhibitory molecules in the CNS milieu after injury. Following genetic studies that showed modest effects of deleting various extrinsic inhibitors on axon regeneration (references in [2]), attention was then turned to promoting neuron-intrinsic ability to regrow axons. The importance of neuron-intrinsic contribution to axon regeneration was first demonstrated by the conditioning effect of a prior peripheral nerve injury that boosts regeneration of the central branches of sensory axons in the absence of any modification to the CNS environment [3, 4] . Although the regenerative potential of CNS neurons declines with age, injured adult CNS axons can be coaxed to grow by activating neuron-intrinsic signaling pathways [5, 6] . While a general distinction is made between extrinsic and intrinsic factors, these programs interact, as extrinsic factors converge on neuronal intracellular signaling pathways.
Axon regeneration: extrinsic regulators
Comparative studies of the growth-permissive environment of the peripheral nervous system (PNS) and the growth-inhibitory environment of the CNS after injury identified prolonged exposure to CNS myelin-derived inhibitors and the formation of the glial scar as two major factors contributing to the regenerative failure of the CNS [7] . Axotomy generates cellular breakdowns at locations proximal and distal to the injury site in both the PNS and CNS. Whereas myelin debris is rapidly cleared in the PNS by Schwann cells, macrophages, and endogenous antibodies to allow for axon regeneration, it persists in the CNS 
